The following table summarizes share-based compensation expense (benefit) and the related income tax benefit recognized for our share-based awards and stock options:


	Three Months Ended				Six Months Ended
	June 30, 2026		June 30, 2025		June 30, 2026		June 30, 2025

	(in thousands)

Share-based compensation expense from continuing operations	$	42,644	$	33,312	$	89,294	$	63,600
Share-based compensation expense from discontinued operations	—		6,498		(7,145)		15,950
Total share-based compensation expense	$	42,644	$	39,810	$	82,149	$	79,550

Total income tax benefit	$	3,200	$	12,269	$	8,580	$	18,534

The following discussion of our share-based compensation awards includes awards related to continuing and discontinued operations.

The following table summarizes the changes in unvested restricted stock and performance awards for the six months ended June 30, 2026:


	Shares	Weighted-Average Grant-Date Fair Value

	(in thousands)

Unvested at December 31, 2025	2,465	$110.54
Granted	1,578	75.37
Vested	(1,300)	107.24
Forfeited	(270)	105.25
Unvested at June 30, 2026	2,473	$89.70

The total fair value of restricted stock and performance awards vested during the six months ended June 30, 2026 and 2025 was $139.4 million and $136.1 million, respectively.

For restricted stock and performance awards, we recognized compensation expense of $33.2 million and $36.8 million during the three months ended June 30, 2026 and 2025, respectively, and $52.1 million and $72.7 million during the six months ended June 30, 2026 and 2025, respectively. As of June 30, 2026, there was $152.0 million of unrecognized compensation expense related to unvested restricted stock and performance awards that we expect to recognize over a weighted-average period of 1.9 years.


	Options	Weighted-Average Exercise Price	Weighted-Average Remaining Contractual Term	Aggregate Intrinsic Value

	(in thousands)		(years)	(in millions)

Outstanding at December 31, 2025	931	$113.43	5.8	$0.6
Granted	—	—
Forfeited	(139)	122.71
Exercised	(16)	66.19
Outstanding at June 30, 2026	776	$112.77	5.5	$0.1

Options vested and exercisable at June 30, 2026	599	$114.39	4.6	$0.1

We recognized compensation expense for stock options of $1.7 million and $1.9 million during the three months ended June 30, 2026 and 2025, respectively, and $3.5 million and $4.4 million during the six months ended June 30, 2026 and 2025, respectively. The aggregate intrinsic value of stock options exercised during the six months ended June 30, 2026 and 2025 was $0.1 million and $1.2 million, respectively. As of June 30, 2026, we had $5.0 million of unrecognized compensation expense related to unvested stock options that we expect to recognize over a weighted-average period of 1.2 years.

There were no stock options granted during the six months ended June 30, 2026. The weighted-average grant-date fair value of stock options granted during the six months ended June 30, 2025 was $43.20. Fair value was estimated on the date of grant using the Black-Scholes valuation model with the following weighted-average assumptions:


									Six Months Ended
									June 30, 2025

Risk-free interest rate									4.01%
Expected volatility									46%
Dividend yield									0.88%
Expected term in years									5

The risk-free interest rate was based on the yield of a zero coupon U.S. Treasury security with a maturity equal to the expected life of the option from the date of the grant. Our assumption on expected volatility was based on our historical volatility. The dividend yield assumption was determined using our average stock price over the preceding year and the annualized amount of our most current quarterly dividend per share. We based our assumptions on the expected term of the options on our analysis of the historical exercise patterns of the options and our assumption on the future exercise pattern of options.